Acorah Software Products - Accounts Production 16.2.850 false true false true No description of principal activity 2 November 2023 31 March 2025 31 March 2025 15254860 Dr Paolo Perella iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15254860 2023-11-01 15254860 2025-03-31 15254860 2023-11-02 2025-03-31 15254860 frs-core:CurrentFinancialInstruments 2025-03-31 15254860 frs-bus:PrivateLimitedCompanyLtd 2023-11-02 2025-03-31 15254860 frs-bus:FilletedAccounts 2023-11-02 2025-03-31 15254860 frs-bus:Micro-entities 2023-11-02 2025-03-31 15254860 frs-bus:AuditExempt-NoAccountantsReport 2023-11-02 2025-03-31 15254860 frs-bus:Director1 2023-11-02 2025-03-31
Registered number: 15254860
Paolo Perella Limited
Unaudited Financial Statements
For the Period 2 November 2023 to 31 March 2025
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 15254860
31 March 2025
£
Fixed assets 544
Current assets 51,369
Creditors: Amounts Falling Due Within One Year (9,716 )
NET CURRENT ASSETS 41,653
TOTAL ASSETS LESS CURRENT LIABILITIES 42,197
Accruals and deferred income (1,284 )
NET ASSETS 40,913
CAPITAL AND RESERVES 40,913

Notes

1. General Information
Paolo Perella Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15254860 . The registered office is Normanby Gateway, Lysaghts Way, Scunthorpe, Lincolnshire , DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Paolo Perella
Director
13/08/2025